CTI BioPharma

$3.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.58%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CTI BioPharma and other stocks, options, and ETFs commission-free!

About CTIC

CTI BioPharma Corp. (DE) Common Stock, also called CTI BioPharma, is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. The listed name for CTIC is CTI BioPharma Corp. (DE) Common Stock.

CEO

Adam R. Craig

Employees

Headquarters

Seattle, Washington

Founded

1991

Market Cap

235.47M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

476.51K

High Today

$3.20

Low Today

$3.11

Open Price

$3.17

Volume

724.21K

52 Week High

$4.03

52 Week Low

$0.62

Collections

CTIC Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours